300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Art
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Real Estate
Enterprise
Community
Media (Entertainment)
Sporting Goods
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Puerto Rico
Oman
Poland
China
Cameroon
Guernsey
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ireland
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Portugal
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Bangladesh
Barbados
Belgium
Europe
Jordan
Qatar
Ethiopia
Austria
Angola
Azerbaijan
Bulgaria
Cyprus
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Lebanon
Liechtenstein
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Korea Investment & Securities, VC Fund

Korea Investment & Securities

VC Fund

Yongdungpo, South Korea

Korea Investment & Securities is a financial investment company that offers brokerage, asset management, and investment banking services.

Total investments:
83
Last investment:
Lead investor:
12%

Last updated:

Industries Korea Investment & Securities invests in

BiotechnologyHealth CareSoftwareInformation TechnologyMedical

Stages Korea Investment & Securities invests in

Series BSeries CSeries AVenture - Series UnknownSeed

Countries Korea Investment & Securities invests in

South KoreaUnited States

Round sizes

Series A $2.2M–$13MSeries B $1.4M–$25MSeries C $4.5M–$45M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$2.2M–$13M
Series B
$1.4M–$25M
Series C
$4.5M–$45M

Investment Focus

Industry

  • Biotechnology 17 (20%)
  • Health Care 16 (19%)
  • Software 14 (17%)
  • Information Technology 12 (14%)
  • Medical 11 (13%)
See all 131 industries →

Stage

  • Series B 23 (28%)
  • Series C 16 (19%)
  • Series A 11 (13%)
  • Venture - Series Unknown 9 (11%)
  • Seed 5 (6%)
See all 16 stages →

Country

  • South Korea 73 (88%)
  • United States 5 (6%)

Team

NameTitleInvestmentsLinksEmail
Jung Il-moon
Jung Il-moon CEO and President
CEO and President Total investments: 1 Find email

Investments

CompanyDescriptionRoundLinks
Flexell Space engages in space solar cells, focusing on improving cost, delivery, design, and power efficiency. $20M / Series A / Jul 14, 2026
Inocras Inc. specializes in whole genome sequencing and analytics, focusing on providing insights for personalized care in cancer and rare diseases. Utilizing artificial intelligence, Inocras aims to revolutionize healthcare by enabling precision medicine. The company offers services to patients, healthcare providers, researchers, and partners,seeking to unlock new possibilities in precision health. With a commitment to innovation, Inocras has introduced products like CancerVision and RareVision, designed to enhance diagnosis and treatment strategies through comprehensive genomic analysis. $20K / Series B / Jul 01, 2026
Coinone is the cryptocurrency exchanges. Under the vision to ‘Bring Blockchain into the World,’ they aspires to lead the new world of finance through blockchain technology. They currently operates the third largest exchange. They prioritizes the protection of clients’ assets and is dedicated to providing the most secure investing environment. $106.4M / Private Equity / May 29, 2026
Coinone is the cryptocurrency exchanges. Under the vision to ‘Bring Blockchain into the World,’ they aspires to lead the new world of finance through blockchain technology. They currently operates the third largest exchange. They prioritizes the protection of clients’ assets and is dedicated to providing the most secure investing environment. $53.2M / Secondary Market / May 29, 2026
FairSquare Labs offers services for digital asset management and Web 3. Blockchain innovations like the security token mainnet, multi-signature and MPC wallets, de-fi, and dex were created by them. They also mine, stake, trade, and fund crypto venture capital initiatives as well. They believe that the strength of their team places us in a uniqueposition to bridge the gap between traditional and digital assets. Series B / Apr 15, 2026
Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases using its AI-based drug design platform technologies. $29M / Series B / Feb 09, 2026
1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients. We are focused on discovery and development of innovative first-in-class therapeutic candidates with highly likelihood of clinical success. 1STBIO currently has 24 employees with expertise in biochemistry, medicinal chemistry,pharmacology, and business development. We are working as a core expertise team of drug discovery/development and are rigorously connected to R&D networking of academia, hospitals, industry, CRO’s and investors in Korea, China and US. Our ultimate goal is to use our experience and knowledge to discover and develop effective molecular therapeutics for patients. $21.9M / Series D / Jan 26, 2026
Robocon is a machinery manufacturing company that provides robot automation solutions specialised in construction and steel fields. Robocon equipment helps in the field of rebar processing and can be installed on any site, including a portable container module. $6.9M / Series C / Jan 09, 2026
Pharos iBio Co. specializing in drug development that develops treatments for intractable diseases. $12.9M / Post-IPO Debt / Dec 04, 2025
Galaxy operates a metaverse platform designed to provide users with infinite content. The company was founded in 2019 and is headquartered in Seoul, Republic of Korea. $69.9M / Venture - Series Unknown / Nov 03, 2025
See all 83 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Art
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Real Estate
Enterprise
Community
Media (Entertainment)
Sporting Goods
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Puerto Rico
Oman
Poland
China
Cameroon
Guernsey
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ireland
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Portugal
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Argentina
Bangladesh
Barbados
Belgium
Europe
Jordan
Qatar
Ethiopia
Austria
Angola
Azerbaijan
Bulgaria
Cyprus
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Lebanon
Liechtenstein
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Korea Investment & Securities invest in?

Korea Investment & Securities invests primarily in Biotechnology, Health Care and Software startups, most often at Series B and Series C stage. Most of the 83 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Korea Investment & Securities's check size?

Korea Investment & Securities typically joins rounds of $2.2M–$13M at Series A, $1.4M–$25M at Series B and $4.5M–$45M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Korea Investment & Securities participates in.

How do I contact Korea Investment & Securities?

Public channels for Korea Investment & Securities include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Korea Investment & Securities?

The team at Korea Investment & Securities includes Jung Il-moon (CEO and President). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Korea Investment & Securities Korea Investment & Securities Find emails